Philip Morris International, babban kamfanin taba sigari, ya shiga kasuwancin cannabinoid a hukumance.

Philip Morris International, babban kamfanin taba sigari, ya shiga kasuwancin cannabinoid a hukumance.

Menene ma'anar wannan? Daga 1950s zuwa 1990s, ana ɗaukar shan taba a matsayin "mai sanyi" al'ada har ma da kayan haɗi a duniya. Hatta taurarin Hollywood suna yawan nuna shan taba a cikin fina-finai, yana sa su bayyana a matsayin alamomi masu laushi. Shan taba ya zama ruwan dare kuma an yarda dashi a duniya. Duk da haka, wannan yanayin bai daɗe ba, saboda ba za a iya yin watsi da shaidar cutar kansa da sauran matsalolin kiwon lafiya da ke haifar da sigari a ƙarshe ba. Da yawa daga cikin ’yan tabar taba sun haifar da yaduwar sigari, wanda hakan ya sa mutane su samu sauki. Philip Morris International (PMI) yana ɗaya daga cikin manyan direbobi, kuma har yau, ya kasance mafi girma a cikin masana'antar taba. A cewar Hukumar Lafiya ta Duniya, shan taba yana haifar da mutuwar kusan miliyan 8 a duniya. Babu shakka, tare da haɓakar marijuana, Philip Morris International shima yana son ɗan guntun kek.

Tarihin Sha'awar Kamfanin Philip Morris a Cannabis

Idan ka duba tarihin sha'awar wannan giant taba ta marijuana, za ka iya mamakin ganin cewa ana iya gano sha'awar Philip Morris akan marijuana tun 1969, tare da wasu takaddun cikin gida da ke tabbatar da cewa kamfanin yana sha'awar yuwuwar marijuana. Yana da kyau a lura cewa ba wai kawai suna ganin marijuana a matsayin samfur mai yuwuwa ba, har ma a matsayin masu fafatawa. A gaskiya ma, wata sanarwa daga 1970 har ma ta nuna yiwuwar Philip Morris ya amince da halatta marijuana. Saurin ci gaba zuwa 2016, Philip Morris ya yi babban jarin da ya kai dala miliyan 20 a Syqe Medical, wani kamfanin fasahar kere-kere na Isra'ila wanda ya kware kan marijuana na likitanci. A wannan lokacin, Syqe yana haɓaka ƙwayar maganin cannabis na likita wanda zai iya ba marasa lafiya takamaiman allurai na maganin cannabis. A cewar yarjejeniyar, Syqe zai kuma yi aiki kan samar da wasu fasahohi na musamman don baiwa Philip Morris damar rage illar da shan taba ke haifarwa ga lafiya. A cikin 2023, Philip Morris ya cimma yarjejeniya don siyan Syqe Medical akan dala miliyan 650, muddin Syqe Medical ya cika wasu sharudda. A cikin wani rahoto na Calcalist, wannan ciniki wani ci gaba ne, tare da bayanin ƙasa shine cewa idan Syqe Medical's inhaler ya wuce gwajin asibiti, Philip Morris zai ci gaba da samun duk hannun jarin kamfanin na adadin da aka ambata.

Bayan haka, Philip Morris ya sake yin wani motsi na shiru!

A cikin Janairu 2025, Philip Morris ya fitar da sanarwar manema labarai da ke ba da cikakken bayani game da haɗin gwiwa da kafa haɗin gwiwa tsakanin reshenta na Vectra Fertin Pharma (VFP) da kamfanin fasahar kere-kere na Kanada Avicanna, wanda ke mai da hankali kan haɓaka magungunan cannabinoid. A cewar sanarwar, kafa wannan haɗin gwiwar na da nufin haɓaka dama da bincike na cannabis. Avicanna ya riga ya ɗauki matsayi mai mahimmanci a fagen kiwon lafiya. Koyaya, sanarwar manema labarai da kyar ba ta ambaci hannun Philip Morris ba, amma a bayyane yake cewa ƙwararrun masu shan sigari sun daɗe suna sha'awar masana'antar cannabis. Tun farkon 2016, lokacin da suka fara haɗin gwiwa tare da Syqe Medical, ya nuna sha'awar kamfanin a fannin kiwon lafiya, kuma wannan haɗin gwiwa tare da Avicanna ya ƙara ƙarfafa wannan.

Canje-canje a cikin halayen mabukaci da halaye

A zahiri, yana da ma'ana ga ƙwararrun masu shan sigari su canza zuwa cannabis ko fannin kiwon lafiya. Kamar yadda ake cewa, idan ba za ku iya kayar da su ba, to ku shiga su! A bayyane yake cewa adadin masu shan taba yana raguwa a cikin 'yan shekarun nan. Matasan masu amfani yanzu sun rabu da matsalolin taba da barasa kuma sun koma shan tabar wiwi. Philip Morris ba shine katon taba sigari kadai ke sha'awar kasuwar cannabis ba. Tun daga farkon 2017, Kamfanin Altria Group na Amurka ya fara karkatar da kasuwancin sigari kuma ya kashe dala biliyan 1.8 ga shugaban cannabis na Kanada Cronos Group. Ƙungiyar Altria ta mallaki manyan kamfanoni na Amurka da dama, ciki har da Philip Morris, har ma da gidan yanar gizon ta yanzu yana da taken "Bayan shan taba". Wani katafaren taba sigari, Tobacco American Tobacco (BAT), shima ya nuna sha'awar tabar wiwi. A wani lokaci yanzu, Taba ta Amurka ta Biritaniya tana binciken samfuran cannabis, musamman allurar CBD da THC cikin sigari ta e-cigare da aka sayar a ƙarƙashin samfuran Vuse da Vype. A cikin 2021, Taba ta Amurka ta Burtaniya ta fara gwada samfuran CBD a cikin Burtaniya. Renault Tobacco, wanda kuma ke da alaƙa da Taba ta Amurka ta Biritaniya, ya yi la'akari da shiga masana'antar cannabis. Dangane da takaddun cikinta, tun farkon shekarun 1970s, Kamfanin Renault Tobacco ya ga marijuana a matsayin dama kuma mai fafatawa.

Takaitawa

Daga ƙarshe, marijuana ba barazana ce ta gaske ga masana'antar taba ba. Yakamata masana'antar sigari su fadakar da kansu domin hakika taba sigari na iya haifar da cutar daji da kuma haddasa asarar rayuka. A gefe guda, marijuana aboki ne maimakon maƙiyi: kamar yadda haɓakar halatta doka da ci gaba da haɓaka shan tabar ke tabbatar da cewa tana iya ceton rayuka da gaske. Koyaya, dangantakar dake tsakanin taba da marijuana tana ci gaba da haɓakawa. Ta hanyar halalta marijuana, ’yan katangar taba za su iya koyo daga ƙalubale da damar da marijuana ke fuskanta. Koyaya, abu ɗaya a bayyane yake: raguwar shan taba hakika babbar dama ce ga cannabis, yayin da mutane da yawa ke fatan amfani da samfuran lafiya don maye gurbin taba. Don yin hasashe, za mu iya ci gaba da ganin ƙwararrun masu shan sigari suna saka hannun jari a kamfanonin cannabis, kamar yadda muka gani a cikin misalin da aka ambata a sama. Wannan haɗin gwiwar tabbas labari ne mai kyau ga masana'antu biyu, kuma muna fatan ganin ƙarin irin wannan haɗin gwiwar!